Clinical And Patient Educators Association
- Assets
- $248.7k
- Revenue
- $467.7k
- Investments
- $0.0
- Employees
- 0
- Location
- Denver, CO
- Founding
- 01/2011
- Data as of
- 12/2022
- EIN
- 27-2280465
Organization Overview
Clinical And Patient Educators Association is located in Denver, CO. The organization was established in 2011. According to its NTEE Classification (E03) the organization is classified as: Professional Societies & Associations, under the broad grouping of Health Care and related organizations. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Clinical And Patient Educators Association is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 12/2022, Clinical And Patient Educators Association generated $467.7k in total revenue. This represents a relatively dramatic decline in revenue. Over the past 8 years, the organization has seen revenues fall by an average of (6.6%) each year. All expenses for the organization totaled $407.2k during the year ending 12/2022. As we would expect to see with falling revenues, expenses have declined by (8.9%) per year over the past 8 years. You can explore the organizations financials more deeply in the financial statements section below.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2022
Describe the Organization's Mission:
Part 3 - Line 1
SEE SCHEDULE ODEVELOPING QUALITY, INNOVATIVE EDUCATION FOR HEALTHCARE PRACTITIONERS AND THE PATIENT COMMUNITIES THEY SERVE.
Describe the Organization's Program Activity:
Part 3 - Line 4a
SEE SCHEDULE O.MANAGING THE RETINAL VEIN OCCLUSION PATIENT JOURNEY FROM DIAGNOSIS TO TREATMENT WAS AN ONLINE, ENDURING ACTIVITY HOSTED ON HEALIO FOR 1 CALENDAR YEAR. THE GOALS OF THIS ACTIVITY WERE TO HELP LEARNERS: (1) OUTLINE AN EVIDENCE-BASED APPROACH TO THE ASSESSMENT OF SYSTEMIC AND LOCAL RISK FACTORS FOR RETINAL VEIN OCCLUSION (RVO), (2) RECOGNIZE HOW RVO OUTCOMES ACHIEVED IN CLINICAL TRIALS CAN BE ATTAINED IN REAL WORK PRACTICE, (3) DISCUSS HOW MACHINE LEARNING AND SUB ANALYSES INFORM BETTER CLINICAL DECISION MAKING ON DOSING FREQUENCY AND TREATMENT OUTCOMES IN RVO PATIENTS, (4) EXAMINE HOW IMAGING INNOVATIONS CAN IMPROVE THE DIAGNOSIS AND MANAGEMENT OF RVO, AND (5) REVIEW CASE-SPECIFIC RVO MANAGEMENT PEARLS TO OPTIMIZE PATIENT CARE. THE ORGANIZATION PROVIDED 1.0 AMA PRA CATEGORY 1 CREDIT FOR THE ACTIVITY.
OTHER PROGRAM EXPENSES THAT ARE NOT SPECIFICALLY ASSOCIATED WITH A PROGRAM SERVICE ACCOMPLISHMENTS. EXPENSES INCLUDING INFORMATION TECHNOLOGY, ACCREDITATION, AND MEMBERSHIP FEES.
SEE SCHEDULE O.GOING THE DISTANCE AGAIN: SUSTAINED THERAPIES FOR OCULAR INFLAMMATION WAS A LIVE, IN-PERSON CONFERENCE, HOSTED IN CHICAGO, IL. THE GOALS OF THIS ACTIVITY WERE TO HELP LEARNERS: (1) REVIEW DIAGNOSTIC STRATEGIES FOR CLASSIFYING UVEITIS, (2) IDENTIFY WHICH IMAGING FINDINGS WERE IMPORTANT FOR PATIENT MONITORING AND PROGNOSIS, (3) EVALUATE APPROACHES FOR MANAGING NONINFECTIOUS UVEITIS, (4) DESCRIBE THE BENEFITS AND RISKS OF UVEITIS STEROID IMPLANT OPTIONS BASED ON SPECIFIC PATIENT CHARACTERISTICS, AND (5) USE UVEITIS CASE DISCUSSIONS TO ASSESS HOW TRIAL RESULTS INFLUENCE CLINICAL PRACTICE. THE ORGANIZATION PROVIDED 1.5 AMA PRA CATEGORY 1 CREDITS FOR THE ACTIVITY.
SEE SCHEDULE O.THE CORNEAL PHYSICIAN SYMPOSIUM WAS A VIRTUAL SYMPOSIUM ON NOVEMBER 19, 2022. THE GOALS OF THIS ACTIVITY WERE TO HELP LEARNERS: (1) IDENTIFY THE PREOPERATIVE DIAGNOSTIC AND TREATMENT ALGORITHM FOR OCULAR SURFACE DISEASE (OSD), (2) EVALUATE THE IMPACT OF GLAUCOMA THERAPY ON THE OCULAR SURFACE, (3) RECOGNIZE THE MOST APPROPRIATE THERAPEUTIC OPTION FOR PATIENTS SUFFERING FROM OSD, (4) DESCRIBE HOW TO DIAGNOSE AND TREAT NEUROPATHIC EYE PAIN, NEUROTROPIC KERATITIS, AND THE ROLE OF IMMUNOSUPPRESSION AND SYSTEMIC TREATMENTS FOR ANTERIOR SEGMENT SURGERY, (5) DESCRIBE THE CURRENT STATE OF TOPOGRAPHY GUIDED AND WAVEFRONT GUIDED LASER VISION CORRECTION IN THE US, (6) EXAMINE THE FUTURE OF LASER VISION CORRECTION, (7) DESCRIBE THE CURRENT DIAGNOSTIC TOOLS, TREATMENT PROTOCOLS AND OUTCOMES FOR COLLAGEN CROSSLINKING, (8) RECOGNIZE THE SURGICAL TECHNIQUES FOR CHALLENGING CASES INCLUDING ENDOTHELIAL KERATOPLASTY, TECHNIQUES FOR COMBINED CORNEAL SURGERY COUPLED WITH COMPLEX CATARACT SURGICAL, AND OCULAR SURFACE RECONSTRUCTION, AND (9) DISCUSS THE MOST UP-TO-DATE DIAGNOSTIC AND TREATMENT APPROACHES TO INFECTIOUS KERATITIS. THE ORGANIZATION PROVIDED 6.0 AMA PRA CATEGORY 1 CREDITS FOR THE ACTIVITY.
Get More from Intellispect for FreeCreate a free account to get more data, nonprofit salaries, advanced search and more.
Board, Officers & Key Employees
| Name (title) | Role | Hours | Compensation |
|---|---|---|---|
Rametta Thomas President | OfficerTrustee | 2 | $0 |
Bailey Darlyne Chair Of The Board | OfficerTrustee | 3 | $0 |
Polin Theodore Vice Chair Of The Board | OfficerTrustee | 2 | $0 |
Campbell Hugh Board Member | Trustee | 2 | $0 |
Mincey Karen Board Member | Trustee | 2 | $0 |
Wall Williams Saundra Board Member | Trustee | 2 | $0 |
Outside Vendors & Contractors
| Vendor Name (Service) | Service Year | Compensation |
|---|---|---|
Paradigm Medical Communications Educational Partner | 12/30/16 | $298,064 |
Diversified Health Communications Educational Partner | 12/30/16 | $191,075 |
Financial Statements
| Statement of Revenue | |
|---|---|
| Federated campaigns | $0 |
| Membership dues | $0 |
| Fundraising events | $0 |
| Related organizations | $0 |
| Government grants | $0 |
| All other contributions, gifts, grants, and similar amounts not included above | $467,713 |
| Noncash contributions included in lines 1a–1f | $0 |
| Total Revenue from Contributions, Gifts, Grants & Similar | $467,713 |
| Total Program Service Revenue | $0 |
| Investment income | $0 |
| Tax Exempt Bond Proceeds | $0 |
| Royalties | $0 |
| Net Rental Income | $0 |
| Net Gain/Loss on Asset Sales | $0 |
| Net Income from Fundraising Events | $0 |
| Net Income from Gaming Activities | $0 |
| Net Income from Sales of Inventory | $0 |
| Miscellaneous Revenue | $0 |
| Total Revenue | $467,713 |
| Statement of Expenses | |
|---|---|
| Grants and other assistance to domestic organizations and domestic governments. | $0 |
| Grants and other assistance to domestic individuals. | $0 |
| Grants and other assistance to Foreign Orgs/Individuals | $0 |
| Benefits paid to or for members | $0 |
| Compensation of current officers, directors, key employees. | $0 |
| Compensation of current officers, directors, key employees. | $0 |
| Compensation to disqualified persons | $0 |
| Other salaries and wages | $0 |
| Pension plan accruals and contributions | $0 |
| Other employee benefits | $0 |
| Payroll taxes | $0 |
| Fees for services: Management | $0 |
| Fees for services: Legal | $380 |
| Fees for services: Accounting | $9,713 |
| Fees for services: Lobbying | $0 |
| Fees for services: Fundraising | $0 |
| Fees for services: Investment Management | $0 |
| Fees for services: Other | $0 |
| Advertising and promotion | $5,030 |
| Office expenses | $1,069 |
| Information technology | $3,360 |
| Royalties | $0 |
| Occupancy | $0 |
| Travel | $0 |
| Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
| Conferences, conventions, and meetings | $0 |
| Interest | $0 |
| Payments to affiliates | $0 |
| Depreciation, depletion, and amortization | $0 |
| Insurance | $0 |
| All other expenses | $0 |
| Total functional expenses | $407,150 |
| Balance Sheet | |
|---|---|
| Cash—non-interest-bearing | $138,124 |
| Savings and temporary cash investments | $0 |
| Pledges and grants receivable | $0 |
| Accounts receivable, net | $55,000 |
| Loans from Officers, Directors, or Controlling Persons | $0 |
| Loans from Disqualified Persons | $0 |
| Notes and loans receivable | $0 |
| Inventories for sale or use | $0 |
| Prepaid expenses and deferred charges | $55,577 |
| Net Land, buildings, and equipment | $0 |
| Investments—publicly traded securities | $0 |
| Investments—other securities | $0 |
| Investments—program-related | $0 |
| Intangible assets | $0 |
| Other assets | $0 |
| Total assets | $248,701 |
| Accounts payable and accrued expenses | $61,126 |
| Grants payable | $0 |
| Deferred revenue | $87,112 |
| Tax-exempt bond liabilities | $0 |
| Escrow or custodial account liability | $0 |
| Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
| Secured mortgages and notes payable | $0 |
| Unsecured mortgages and notes payable | $0 |
| Other liabilities | $0 |
| Total liabilities | $148,238 |
| Net assets without donor restrictions | $100,463 |
| Net assets with donor restrictions | $0 |
| Capital stock or trust principal, or current funds | $0 |
| Paid-in or capital surplus, or land, building, or equipment fund | $0 |
| Retained earnings, endowment, accumulated income, or other funds | $0 |
| Total liabilities and net assets/fund balances | $248,701 |